Epirubicin, folinic acid, fluorouracil, and etoposide in the treatment of advanced gastric cancer: Phase II study of the southern italy oncology group (GOIM)
In the authors' previous experience, the addition of epidoxorubicin to the FA-FU regimen obtained a better response rate than that of FA-FU alone in patients with advanced gastric cancer. Furthermore, considering the good efficacy and mild toxicity observed with the addition of etoposide to the...
Gespeichert in:
Veröffentlicht in: | American journal of clinical oncology 1999-06, Vol.22 (3), p.262-266 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!